Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial
Ying Mao(Fudan University), Liang-Fu Zhou(Fudan University), Yu Yao(Qinghai University), Hong Shen(Nanfang Hospital), Xiang Zhang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhiyong Li(Jingdezhen University), Chao You(China Meteorological Administration), Xuejun Yang(Dali University), Xiang Wang(Sichuan University), Ji-Sheng Wang(Capital Medical University), Zhong-Ping Chen(Tianjin Agricultural University), Wen-Bin Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Ren-Zhi Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shu-Yuan Yang(Tianjin Medical University General Hospital), Li-Wei Zhang(Capital Medical University), Yi-Cheng Lu(Second Military Medical University), Jian-min Zhang(Second Affiliated Hospital of Zhejiang University), Qun-Ying Yang(Sun Yat-sen University), Hai-Ning Zhen(Fudan University), Song-Tao Qi(Nanfang Hospital), Ju-Xiang Chen(Second Military Medical University)
Cited by 20
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial
|The Lancet|2023|385
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345